IVES for Treatment of UUI and OAB (NCT02992509) | Clinical Trial Compass
CompletedEarly Phase 1
IVES for Treatment of UUI and OAB
United States17 participantsStarted 2014-12
Plain-language summary
The pilot study is intended to show the efficacy of intravesical electrical stimulation in treating overactive bladder with or without frequency and/or urgency urinary incontinence.
Who can participate
Age range18 Years – 90 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female
* 18-90 years old
* Urinary urge incontinence OR overactive bladder
* Prior trial of medical treatment for UUI or OAB
Exclusion Criteria:
* pelvic organ prolapse greater than stage 1
* multiple sclerosis
* parkinson's disease
* spinal cord injury
* long-term DM type I
* prior surgeries that may affect innervation of the detrusor nerves or the spinal cord
* pregnancy
* pacemaker/defibrillator
* PVR \>150ml
* dementia
* Stress urinary incontinence
* intravesical botox injection within 1 year, PTNS within 6 months, or medical treatment for OAB within 3 weeks; bulking agent injection within 6 months